Tumor tissue staining for CD206, CD163, and CD68, which are used to measure the abundance of immune infiltrates, including T cells and both M1 and M2 macrophages, also did not find significant differences by treatment group in either sex (Figure 4). The gene discussed is CD163; the disease is neoplasm.